China Cord Blood Corporation (NYSE:CO) will announce its earnings results after the market closes on Wednesday, November 15th.

China Cord Blood Corporation (NYSE:CO) last announced its earnings results on Wednesday, August 23rd. The company reported C$0.09 earnings per share (EPS) for the quarter. The company had revenue of C$33.07 million for the quarter. China Cord Blood Corporation had a return on equity of 8.64% and a net margin of 22.07%.

China Cord Blood Corporation (NYSE CO) opened at C$10.87 on Monday. The stock has a market capitalization of $1,310.97, a P/E ratio of 37.48 and a beta of 0.95. China Cord Blood Corporation has a 1 year low of C$4.27 and a 1 year high of C$14.95.

Separately, BidaskClub raised China Cord Blood Corporation from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, August 1st.

An institutional investor recently raised its position in China Cord Blood Corporation stock. State Street Corp grew its position in shares of China Cord Blood Corporation (NYSE:CO) by 1.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,056 shares of the company’s stock after buying an additional 506 shares during the period. State Street Corp’s holdings in China Cord Blood Corporation were worth $284,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 13.04% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “China Cord Blood Corporation (CO) Scheduled to Post Quarterly Earnings on Wednesday” was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at https://www.watchlistnews.com/china-cord-blood-corporation-co-scheduled-to-post-quarterly-earnings-on-wednesday/1699004.html.

China Cord Blood Corporation Company Profile

China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.

Earnings History for China Cord Blood Corporation (NYSE:CO)

Receive News & Ratings for China Cord Blood Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.